Patents Assigned to JDS Therapeutics, LLC
-
Patent number: 11857594Abstract: Disclosed herein are compositions for treating, ameliorating, preventing, or reducing the symptoms associated with menopause and/or hot flashes. The compositions disclosed herein comprise a curcumin composition, a green tea extract composition, and a phycocyanin composition that act as neurokinin 3 receptor antagonists. Also described herein are methods utilizing the aforementioned compositions.Type: GrantFiled: October 18, 2022Date of Patent: January 2, 2024Assignee: JDS Therapeutics, LLCInventors: James R. Komorowski, Sarah Sylla
-
Publication number: 20230346865Abstract: The present application is directed to composition comprising various maca extracts and the use of such compositions for treating certain diseases, disorders, and conditions.Type: ApplicationFiled: July 7, 2023Publication date: November 2, 2023Applicant: JDS Therapeutics, LLCInventors: James R. Komorowski, Sara Perez Ojalvo
-
Patent number: 11801224Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.Type: GrantFiled: March 4, 2022Date of Patent: October 31, 2023Assignee: JDS THERAPEUTICS, LLCInventor: James R. Komorowski
-
Patent number: 11779627Abstract: Disclosed herein are compositions for treating, ameliorating, preventing, or reducing the symptoms associated with menopause and/or hot flashes. The compositions disclosed herein comprise a curcumin composition, a green tea extract composition, and a phycocyanin composition that act as neurokinin 3 receptor antagonists. Also described herein are methods utilizing the aforementioned compositions.Type: GrantFiled: June 5, 2023Date of Patent: October 10, 2023Assignee: JDS THERAPEUTICS, LLCInventors: James R. Komorowski, Sarah Sylla
-
Patent number: 11752186Abstract: The present application is directed to composition comprising various maca extracts and the use of such compositions for treating certain diseases, disorders, and conditions.Type: GrantFiled: November 27, 2018Date of Patent: September 12, 2023Assignee: JDS Therapeutics, LLCInventors: James R. Komorowski, Sara Perez Ojalvo
-
Patent number: 11241388Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.Type: GrantFiled: July 29, 2019Date of Patent: February 8, 2022Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski
-
Patent number: 10967026Abstract: The present application is directed to composition comprising various maca extracts and the use of such compositions for treating certain diseases, disorders, and conditions.Type: GrantFiled: September 4, 2018Date of Patent: April 6, 2021Assignee: JDS Therapeutics, LLCInventors: James R. Komorowski, Sara Perez Ojalvo
-
Patent number: 10363222Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.Type: GrantFiled: July 21, 2016Date of Patent: July 30, 2019Assignee: JDS Therapeutics, LLCInventor: James R Komorowski
-
Patent number: 10265364Abstract: The present application is directed to composition comprising various maca extracts and the use of such compositions for treating certain diseases, disorders, and conditions.Type: GrantFiled: July 19, 2017Date of Patent: April 23, 2019Assignee: JDS Therapeutics, LLCInventors: James R. Komorowski, Sara Perez Ojalvo
-
Patent number: 10245325Abstract: Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.Type: GrantFiled: June 12, 2017Date of Patent: April 2, 2019Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski
-
Patent number: 9675702Abstract: Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.Type: GrantFiled: July 21, 2015Date of Patent: June 13, 2017Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski
-
Patent number: 9597404Abstract: Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.Type: GrantFiled: July 21, 2015Date of Patent: March 21, 2017Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski
-
Patent number: 9421170Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.Type: GrantFiled: March 9, 2015Date of Patent: August 23, 2016Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski
-
Patent number: 9028879Abstract: The embodiments disclosed herein relate to compositions for enhancing brain glucose transporters, such as GLUT1 and GLUT3, and methods of treating and/or preventing diseases or disorders associated with the regulation GLUT1 and GLUT3. Also provided are compositions that include chromium and an agent that targets the brain or the central nervous system. Further provided are improved methods of delivering therapeutic agents that target the brain and/or central nervous system.Type: GrantFiled: June 30, 2010Date of Patent: May 12, 2015Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski
-
Patent number: 9005637Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.Type: GrantFiled: April 5, 2013Date of Patent: April 14, 2015Assignee: JDS Therapeutics, LLCInventor: James R Komorowski
-
Patent number: 8933022Abstract: A composition comprising chromium and insulin and/or a chromium-insulin complex, its method of preparation, and its use in the prevention and treatment of hypoglycemia and hypoglycemia-related conditions. This composition can be administered in numerous ways, including parenterally, intranasally, and orally. The composition stabilizes serum glucose levels and has a synergistic effect compared to chromium and insulin administered separately.Type: GrantFiled: March 1, 2012Date of Patent: January 13, 2015Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski
-
Publication number: 20130323287Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.Type: ApplicationFiled: April 5, 2013Publication date: December 5, 2013Applicant: JDS Therapeutics, LLCInventor: JDS Therapeutics, LLC
-
Patent number: 8586061Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.Type: GrantFiled: December 22, 2009Date of Patent: November 19, 2013Assignee: JDS Therapeutics, LLCInventor: James R. Komorowski